| Primary |
| Idiopathic Thrombocytopenic Purpura |
12.2% |
| Guillain-barre Syndrome |
10.2% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
8.2% |
| Blood Immunoglobulin G Decreased |
6.1% |
| Encephalitis |
6.1% |
| Immunodeficiency Common Variable |
6.1% |
| Muscular Weakness |
6.1% |
| Autoimmune Thrombocytopenia |
4.1% |
| Dermatomyositis |
4.1% |
| Hypogammaglobulinaemia |
4.1% |
| Kawasaki's Disease |
4.1% |
| Miller Fisher Syndrome |
4.1% |
| Polymyositis |
4.1% |
| Radiculopathy |
4.1% |
| Selective Igg Subclass Deficiency |
4.1% |
| Thrombocytopenic Purpura |
4.1% |
| Acute Lymphocytic Leukaemia |
2.0% |
| Bruton's Agammaglobulinaemia |
2.0% |
| Capillary Leak Syndrome |
2.0% |
| Immunomodulatory Therapy |
2.0% |
|
| Vomiting |
17.6% |
| Tachycardia |
11.8% |
| Pyrexia |
9.8% |
| Renal Tubular Necrosis |
7.8% |
| Anaphylactic Reaction |
5.9% |
| Renal Failure Acute |
5.9% |
| Sepsis |
5.9% |
| Tremor |
5.9% |
| Hepatitis C |
3.9% |
| Sinus Tachycardia |
3.9% |
| Suspected Transmission Of An Infectious Agent Via Product |
3.9% |
| Abdominal Discomfort |
2.0% |
| Agranulocytosis |
2.0% |
| Blood Pressure Increased |
2.0% |
| Deep Vein Thrombosis |
2.0% |
| Glomerulonephritis Membranous |
2.0% |
| Hepatitis B |
2.0% |
| Hepato-lenticular Degeneration |
2.0% |
| Hypertension |
2.0% |
| Hyperthermia |
2.0% |
|
| Secondary |
| Graft Versus Host Disease |
28.1% |
| Primary Immunodeficiency Syndrome |
15.3% |
| Premedication |
11.6% |
| Demyelinating Polyneuropathy |
9.1% |
| Lymphopenia |
7.4% |
| Immunodeficiency Common Variable |
5.8% |
| Radiculopathy |
4.1% |
| Drug Use For Unknown Indication |
2.9% |
| Diabetes Mellitus |
2.5% |
| Ill-defined Disorder |
2.1% |
| Immunoglobulins Decreased |
1.7% |
| Selective Iga Immunodeficiency |
1.7% |
| Chronic Graft Versus Host Disease |
1.2% |
| Multifocal Motor Neuropathy |
1.2% |
| Opsoclonus Myoclonus |
1.2% |
| Clostridium Colitis |
0.8% |
| Constipation |
0.8% |
| Muscular Weakness |
0.8% |
| Neuralgia |
0.8% |
| Neuropathy Peripheral |
0.8% |
|
| Vomiting |
21.4% |
| Shock |
12.9% |
| Troponin Increased |
12.9% |
| Renal Failure Acute |
11.4% |
| Drug Intolerance |
8.6% |
| Erythema |
4.3% |
| Eczema |
2.9% |
| Haemolysis |
2.9% |
| Myocardial Ischaemia |
2.9% |
| Pyrexia |
2.9% |
| Sinus Tachycardia |
2.9% |
| Thrombocytopenia |
2.9% |
| Anaphylactic Reaction |
1.4% |
| Glomerulonephritis Membranous |
1.4% |
| Hepatitis C |
1.4% |
| Meningitis Aseptic |
1.4% |
| Pericardial Effusion |
1.4% |
| Post Procedural Complication |
1.4% |
| Refusal Of Treatment By Relative |
1.4% |
| Suspected Transmission Of An Infectious Agent Via Product |
1.4% |
|
| Concomitant |
| Infection Prophylaxis |
13.8% |
| Drug Use For Unknown Indication |
11.6% |
| Prophylaxis |
10.5% |
| Chronic Lymphocytic Leukaemia |
6.6% |
| Pemphigus |
6.6% |
| Thrombotic Cerebral Infarction |
6.6% |
| Brain Oedema |
5.0% |
| Allogenic Bone Marrow Transplantation Therapy |
4.4% |
| Product Used For Unknown Indication |
3.9% |
| Haemostasis |
3.3% |
| Hypertension |
3.3% |
| Infection |
3.3% |
| Meningitis |
3.3% |
| Myelodysplastic Syndrome |
3.3% |
| Bacterial Infection |
2.8% |
| Meningitis Haemophilus |
2.8% |
| Prophylaxis Against Graft Versus Host Disease |
2.8% |
| Cytomegalovirus Infection |
2.2% |
| Diabetes Mellitus |
2.2% |
| Acidosis |
1.7% |
|
| Sepsis Neonatal |
12.9% |
| Sepsis |
9.7% |
| Anaemia |
6.5% |
| Febrile Neutropenia |
6.5% |
| Lung Disorder |
6.5% |
| Septic Shock |
6.5% |
| Thrombocytopenia |
6.5% |
| White Blood Cell Count Decreased |
6.5% |
| Arthritis |
3.2% |
| Asthenia |
3.2% |
| Bronchitis |
3.2% |
| Dehydration |
3.2% |
| Depressed Level Of Consciousness |
3.2% |
| Diabetes Mellitus |
3.2% |
| Diarrhoea |
3.2% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.2% |
| Dyspnoea |
3.2% |
| Haemorrhagic Infarction |
3.2% |
| Hypertension |
3.2% |
| Hypoglycaemia |
3.2% |
|
